Institutional Ownership Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA). We have compiled data on the 10 institutions that hold shares in the stock, with a total of 137,970 shares, which have been reported (via 13F filing form) to have a value of $278,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Exchange Traded Concepts, LLC
|
Jan 21, 2025 Q4 2024 |
77,350
shares
|
$156,247
0.0% of portfolio
|
Q3 2024
Reduced 10.31%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
43,524
shares
|
$87,918
0.0% of portfolio
|
Q2 2024
Reduced 1.36%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
11,853
shares
|
$23,943
0.0% of portfolio
|
Q4 2024
Reduced 44.27%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
3,510
shares
|
$7,090
0.0% of portfolio
|
Q4 2024
Reduced 58.25%
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
675
shares
|
$1,363
0.0% of portfolio
|
Q4 2024
Added 229.27%
|
|
|
National Bank Of Canada
|
Feb 12, 2025 Q4 2024 |
450
shares
|
$909
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
307
shares
|
$620
0.0% of portfolio
|
Q3 2024
Reduced 25.49%
|
|
|
Steward Partners Investment Advisory, LLC
|
Feb 06, 2025 Q4 2024 |
200
shares
|
$404
0.0% of portfolio
|
Q4 2023
Reduced 60.0%
|
|
|
Optiver Holding B.V.
Amsterdam, P7 |
Feb 14, 2025 Q4 2024 |
101
shares
|
$204
0.0% of portfolio
|
Q4 2024
Reduced 99.88%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|